LUGPA 2024 Enduring CME Program: Emerging Technologies to Advance Urologic Care in 2025-LUGPA 2024 CME Program Part 1

Video Transcription

Video Summary

The 2024 CME program focused on emerging technologies in urologic care, highlighting the historical and ongoing innovation within the field. Key topics included overactive bladder (OAB) management, advanced therapies, and new technologies in prostate and kidney cancer. The event aimed to introduce participants to cutting-edge advancements, exploring therapies like sacral neuromodulation and its latest developments, as well as the role of implantable and traditional neuromodulation for various conditions beyond OAB. Significant emphasis was placed on understanding and integrating new guidelines that allow for earlier use of advanced therapies in OAB, moving away from a strict linear treatment approach. Discussions also touched on the potential challenges with insurance coverage and patient education to maximize therapy effectiveness. An intriguing session featured the SHURE procedure for kidney stone management, showcasing its efficiency in stone clearance compared to traditional methods. The program concluded with insights into practice management and strategies to tackle physician burnout, underscoring the importance of staying updated with innovations. Overall, the event aimed to equip attendees with knowledge to enhance urologic care practices by embracing new technologies and therapies.

Keywords

urologic care

emerging technologies

overactive bladder

sacral neuromodulation

prostate cancer

kidney cancer

SHURE procedure

advanced therapies

physician burnout